Actualizado 17/02/2009 10:10
- Comunicado -

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile (y 2)

http://www.sanofipasteur.com

http://www.sanofipasteur.us

Contacts: Global Media Relations, Pascal Barollier, T. +33(0)4-37-37-50-38, pascal.barollier@sanofipasteur.com; US Media Relations, Len Lavenda, T. +1-570-957-4446, len.lavenda@sanofipasteur.com

Contenido patrocinado